SMTL ID : 6imx.1

Crystal structure of V30M mutated transthyretin in complex with 18-Crown-6

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

homo-tetramer

Ligands

4 x O4B: 1,4,7,10,13,16-HEXAOXACYCLOOCTADECANE(Non-covalent)

O4B.1: 9 residues within 4Å: Chain A: K.47, L.49, T.138, A.140 Chain C: K.47, L.49, T.138, A.140 Ligands: O4B.3 No protein-ligand interaction detected (PLIP) O4B.2: 15 residues within 4Å: Chain B: M.45, K.47, L.49, E.86, T.138, A.140, V.153 Chain D: M.45, K.47, L.49, E.86, T.138, A.140, V.153 Ligands: O4B.4 No protein-ligand interaction detected (PLIP) O4B.3: 9 residues within 4Å: Chain A: K.47, L.49, T.138, A.140 Chain C: K.47, L.49, T.138, A.140 Ligands: O4B.1 No protein-ligand interaction detected (PLIP) O4B.4: 15 residues within 4Å: Chain B: M.45, K.47, L.49, E.86, T.138, A.140, V.153 Chain D: M.45, K.47, L.49, E.86, T.138, A.140, V.153 Ligands: O4B.2 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yokoyama, T. et al., Crown Ethers as Transthyretin Amyloidogenesis Inhibitors. J. Med. Chem. (2019)

Release Date

2019-03-13

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence